Abbas Hussain

Abbas Hussain is an experienced executive currently serving as Chairman at Asceneuron SA, an innovative biotech company focused on developing therapeutics for neurodegenerative disorders. Concurrently, Abbas holds advisory roles at 4BIO Capital, a venture capital firm specializing in advanced therapies, and CBC Group, an investment firm targeting healthcare and biotechnology in Asia. Additionally, Abbas is a Non-Executive Director and Chair of the Audit & Risk Committee at Alfasigma, a global pharmaceutical company. Previous leadership positions include Chief Executive Officer at Vifor Pharma, Strategic Advisor at CSL Vifor, and Global President at GSK. Abbas possesses extensive international experience with Eli Lilly and Company in various senior roles and has academic credentials from Stanford University, Duke University, and Loughborough University.